Biopharma Shakti Scheme: In Budget 2026, Finance Minister Nirmala Sitharaman has given big relief to the health sector. Under BioPharma Shakti Scheme, medicines for cancer, diabetes and autoimmune disorders will be cheaper. Know the benefits of this scheme.
Finance Minister Nirmala Sitharaman presented the budget on Sunday 1 February. In this budget, special attention was given to health. Finance Minister Sitharaman not only took care of Ayurvedic medicine but also announced to make cancer and diabetes medicines cheaper by waiving the import duty. There was special discussion about Biopharma Shakti Scheme in the budget. Under this scheme, attention was given to non-communicable diseases. Let us know about this in detail.
biologic medicines at low cost
Union Finance Minister Nirmala Sitharaman in Budget 2026 ‘Biopharma Shakti’ Scheme announced. Under this scheme, a budget of Rs 10,000 crore will be made to make India a biopharma hub.Was talked about. The Finance Minister said that the disease burden in India is shifting towards non-communicable diseases, such as diabetes, cancer and autoimmune disorders. In such a situation, it is necessary for the medicines to treat these diseases to be cheap. Research will be done on slow growing medicines in the Biopharma Hub. Along with this, 3 National Institutes will also be prepared, so we will work on this.
Read more: Health Budget 2026: Number of Ayurveda products will increase, big announcement in the budget on health AYUSH
What will be the benefits of Biopharma Shakti Scheme?
- Biopharma will develop as a manufacturing hub, where medicines will be produced domestically.
- India will also create a network of more than 1000 recognized clinical trials sites.
- The poor and middle class will be able to get treatment for cancer, diabetes and autoimmune diseases at low cost.
- Dependence on medicines coming from outside will reduce.
- This will help in making India a global biopharma hub.
What is the condition of cancer and diabetes in India?
India has become the home of diabetes and the country needs affordable treatment. According to ICMR-INDIAB, more than 10.1 crore people in India are suffering from diabetes. The average direct cost of diabetes treatment in India for 1 year ranges between ₹15,000 to ₹35,000. Medicines from the main room are included in the expenses. Lakhs are spent on cancer medicines in a year. In such a situation, medicines for cancer and diabetes becoming cheaper will provide relief.
Read more: Budget 2026: Income tax remains the same, exemption on cancer medicines, 7 high speed rail corridors; 10 big announcements of the budget